{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 11, "transaction_limit": 160, "filters": {"q": "", "ticker": "NRIX", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 11, "acquisition_count": 4, "disposal_count": 7, "acquisition_value": 293020.72, "acquisition_value_label": "$293.0K", "disposal_value": 947751.6368, "disposal_value_label": "$947.8K", "net_value": -654730.9168, "net_value_label": "$-654.7K", "flow_tone": "negative", "largest_value_label": "$580.5K", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 11, "value": "1240772.3568", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$1.2M"}], "days": [{"transaction_date": "2026-06-25", "acquisitions": 2, "disposals": 4, "total": 6, "bar_width": 100.0}, {"transaction_date": "2026-07-02", "acquisitions": 2, "disposals": 3, "total": 5, "bar_width": 83.3}], "side_mix": {"acquisitions": 4, "disposals": 7, "acquisition_share": 36.4, "disposal_share": 63.6}}, "company_flows": [{"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-02", "acquisitions": 4, "disposals": 7, "acquired_value": 293020.72, "acquired_value_label": "$293.0K", "disposed_value": 947751.6368, "disposed_value_label": "$947.8K", "net_value": -654730.9168, "net_value_label": "$-654.7K", "acquisition_share": 36.4, "disposal_share": 63.6, "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}], "company_overview": [{"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-02", "filings": 11, "acquisitions": 4, "disposals": 7, "acquired_value": 293020.72, "acquired_value_label": "$293.0K", "disposed_value": 947751.6368, "disposed_value_label": "$947.8K", "net_value": -654730.9168, "net_value_label": "$-654.7K", "acquisition_share": 36.4, "disposal_share": 63.6, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}], "transactions": [{"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11008.0, "share_price": 23.5616, "transaction_value": 259366.0928, "fetched_at": "2026-07-22T11:03:33.449690+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5787.0, "share_price": 8.72, "transaction_value": 50462.64, "fetched_at": "2026-07-22T11:03:33.458532+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5221.0, "share_price": 1.86, "transaction_value": 9711.06, "fetched_at": "2026-07-22T11:03:33.460261+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 5787.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T11:03:33.457132+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 5221.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T11:03:33.453875+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 28935.0, "share_price": 20.0624, "transaction_value": 580505.544, "fetched_at": "2026-07-16T22:08:21.083563+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 15602.0, "share_price": 8.72, "transaction_value": 136049.44, "fetched_at": "2026-07-16T22:08:21.085115+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "HANSEN, GWENN", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5394.0, "share_price": 20.0, "transaction_value": 107880.0, "fetched_at": "2026-07-16T22:08:21.079001+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 13333.0, "share_price": 7.26, "transaction_value": 96797.58, "fetched_at": "2026-07-16T22:08:21.086529+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 13333.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T22:08:21.081816+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}, {"symbol": "NRIX", "name": "Nurix Therapeutics\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-25", "executive": "RING, CHRISTINE", "executive_title": "Chief Legal Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 15602.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-16T22:08:21.080447+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nrix/", "research_links": {"chart": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/", "report": "/terminal/2a14d988-c858-45ad-88c1-a8f7c00f8ada/report/", "factor": "/factors/ticker/2a14d988-c858-45ad-88c1-a8f7c00f8ada/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}